Oorsprong van het eerstegraads netwerk van Paul F. Glidden
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA.
7
| Private Company | Pharmaceuticals: Major | 7 |
Alpha Therapeutic Corp.
Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA.
5
| Subsidiary | Biotechnology | 5 |
NanoSmart Pharmaceuticals, Inc.
NanoSmart Pharmaceuticals, Inc. BiotechnologyHealth Technology NanoSmart Pharmaceuticals, Inc. is a privately-held corporation based in Laguna Hills, CA. The private company is developing nanoparticle drug delivery platforms, including utilization of anti-nuclear antibody (ANA) to enable targeted drug delivery of existing drug therapies to areas of necrosis present in virtually all solid cancer tumors. Henry J. Smith has been the CEO of the company since 2006.
4
| Private Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Paul F. Glidden via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
PUBLIC STORAGE | Real Estate Investment Trusts | General Counsel | |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Valley Forge Pharmaceuticals, Inc.
Valley Forge Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Valley Forge Pharmaceuticals, Inc. develops ophthalmic pharmaceuticals. It is an early stage ophthalmic pharmaceutical company focused on preventing the development of myopia in children and utilizing proprietary pharmaceutical drugs to control abnormal ocular development. The company is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Epinex Diagnostics, Inc.
Epinex Diagnostics, Inc. Medical SpecialtiesHealth Technology Epinex Diagnostics, Inc. provides medical diagnostics tests and services. It develops multi-parameter diagnostic tests that use disposable strips and biosensors. The company provides services to the hospitals, emergency rooms, wholesale distributors and pharmacies. Epinex Diagnostics was founded in 2002 and is headquartered in Tustin, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tioga Pharmaceuticals, Inc.
Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
COLUCID PHARMACEUTICALS INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
TRUSTFEED CORP. | Financial Conglomerates | President | |
Rice University | College/University | Doctorate Degree | |
University of Leeds | College/University | Doctorate Degree | |
YPSOMED HOLDING AG | Medical Specialties | Director/Board Member | |
Lehigh University | College/University | Graduate Degree Undergraduate Degree | |
Oregon Health & Science University | College/University | Doctorate Degree | |
University of California, Irvine | College/University | Corporate Officer/Principal | |
University of California San Diego | College/University | Undergraduate Degree | |
University of Central Florida | College/University | Graduate Degree | |
University of Oregon | College/University | Undergraduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
BioMedInvest AG I
BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Investment Managers | Corporate Officer/Principal | |
GENE BIOTHERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Biotech Ventures GP Ltd.
Biotech Ventures GP Ltd. Financial ConglomeratesFinance Part of Bellevue Group AG, Biotech Ventures GP Ltd. is a venture capital fund. The company is based in St. Peter Port, UK. | Financial Conglomerates | Corporate Officer/Principal | |
International BioResources LLC
International BioResources LLC Medical/Nursing ServicesHealth Services International BioResources LLC operates IBR plasma donation centers. The company was founded on November 5, 2001 and is headquartered in Lafayette, LA. | Medical/Nursing Services | Chief Operating Officer | |
MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
Beecham Pharmaceuticals | Corporate Officer/Principal | ||
Glaxo, Inc. | Corporate Officer/Principal | ||
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
Diabetes Reference Services, Inc. | Chief Executive Officer | ||
BB Biotech Ventures | Chief Executive Officer | ||
ENTERO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ImmunoTek Bio Centers LLC
ImmunoTek Bio Centers LLC Medical/Nursing ServicesHealth Services ImmunoTek Bio Centers LLC is a bio-technology firm that collects and procures human blood plasma. It specializes in constructing, opening, FDA/EU licensing, and managing multiple plasma collection sites and plasma supply contracts. The company was founded in 2012 and is headquartered in Lafayette, LA. | Medical/Nursing Services | Chief Executive Officer | |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Investment Managers | Private Equity Investor | |
Binx Health Ltd.
Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber. | Miscellaneous Commercial Services | Director/Board Member | |
Alentis Therapeutics AG
Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Ariceum Therapeutics GmbH
Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 36 |
Zwitserland | 8 |
Verenigd Koninkrijk | 4 |
Frankrijk | 2 |
India | 2 |
Sectoraal
Health Technology | 24 |
Consumer Services | 11 |
Finance | 6 |
Commercial Services | 5 |
Health Services | 4 |
Operationeel
Director/Board Member | 55 |
Corporate Officer/Principal | 32 |
President | 15 |
Chief Tech/Sci/R&D Officer | 13 |
Chairman | 10 |
Sterkste connecties
Insiders | |
---|---|
Brian H. Dovey | 40 |
Martin C. Münchbach | 20 |
John H. Parrish | 12 |
Jack Lief | 12 |
James Pennington | 12 |
Brian J. Fields | 9 |
Alison J. Pilgrim | 9 |
Patricia L. Novak | 7 |
Henry J. Smith | 5 |
Jerome Parnell | 5 |
Stephen R. Hanson | 5 |
Christopher M. Bussineau | 5 |
Arno Hartmann | 4 |
Daniel Thiel | 1 |
James Smith | 1 |
- Beurs
- Insiders
- Paul F. Glidden
- Bedrijfsconnecties